test

Sean Tan

@Stempoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$334.017MTotal holdings50
Assets growth rate-1.84%Assets growth rate (2-Q avg)-5.94%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Stempoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 50 positions.

Assets under management

The assets under management (AUM) of Stempoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 334.017M in assets, with a quarterly growth rate of -1.84% and a 2-quarter average growth rate of -5.94%. The portfolio is managed by Sean Tan, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
IMCRImmunocore Hldgs Plc
Recent Activity
Exited
0%
$11.501M
339,351 shares@ $33.89 avg price
MRKMerck & Co Inc
Recent Activity
Exited
0%
$10.153M
81,508 shares@ $124.58 avg price
GSKGsk Plc
Recent Activity
Exited
0%
$9.468M
245,933 shares@ $38.51 avg price
KALVKalvista Pharmaceuticals Inc
Recent Activity
Exited
0%
$8.679M
736,765 shares@ $11.79 avg price
INSMInsmed Inc
Recent Activity
Exited
0%
$5.828M
86,980 shares@ $67.0 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Exited
0%
$5.347M
144,467 shares@ $37.02 avg price
LRMRLarimar Therapeutics Inc
Recent Activity
Exited
0%
$5.107M
704,349 shares@ $7.25 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Exited
0%
$4.592M
101,479 shares@ $45.26 avg price
FULCFulcrum Therapeutics Inc
Recent Activity
Exited
0%
$4.318M
696,464 shares@ $6.21 avg price
SYRESpyre Therapeutics Inc
Recent Activity
Exited
0%
$3.537M
150,450 shares@ $23.52 avg price